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SUMMARY
Breast conserving surgery for breast cancer has led to an increased interest in reconstruction
following mastectomy. The transverse rectus abdominis myocutaneous flap has been proven to
give good results in terms of restoration of body symmetry with near normal contour and
consistency. Furthermore, immediate reconstruction has the advantage of a single procedure
with less psychological morbidity, and reduction in hospital stay and overall complication rate.
The aim of this study was to review our experience with the transverse rectus abdominis
myocutaneousflapprocedureaninitialseriesof45patients. Theoverallcomplicationrateof27%
is similar to that reported in the literature, with no total flap loss and nine patients with partial
flap loss. There was no delay in commencement ofadjuvant chemotherapy or radiotherapy and
we believe our ability to detect local recurrence has not been compromised. We consider that
immediate breast reconstruction is now an integral part of the surgical treatment of breast
cancer.
INTRODUCTION
The change in emphasis in breast cancer surgery
towards breast conservation has, paradoxically,
produced a greater awareness of the needs and
benefits of breast reconstruction following
mastectomy. So much so, that the concept, and
provision (if required), of breast reconstruction
following mastectomy is now an established
component of breast cancer management.' The
goals of reconstruction are both functional and
aesthetic, aiming to restore body symmetry and
to achieve as near normal breast contour and
consistency as possible. This shouldbe achieved
without compromising immediate or subsequent
treatment of cancer.
Reconstruction may be performed at the time of
the initial surgery for cancer (immediate) or at a
later date (delayed). Immediate reconstruction
has advantages over delayed reconstruction.2'3'4
Theseinclude alowerincidence ofpostoperative
psychological morbidity with less disruptions of
bodyimage,5' 67 andtheavoidanceofasecondary
procedure with reduction in total hospitalisation
and overall complication rate. This can be
achieved without compromise of the aesthetic
result or subsequent adjuvant therapy for the
treatment of the cancer.8'9 Many reconstructive
procedures using autologous tissue, prosthetic
materials or a combination of both, have been
described.10 11,12 However, whilst it is a major
procedure, the transverse rectus abdominis
myocutaneous (TRAM) flap is now recognised
as the "gold standard" reconstructive procedure.
Many large series from specialty units have
demonstrated the efficacy and relative safety of
the TRAM flap."3 14' 15 The purpose of this study
was to assess our experience with the TRAM
procedure in a specialist Breast Unit and to
compare our results with those of the major
published series.
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MATERIALS AND METHODS
Thecasenotes ofpatients whohadundergonethe
TRAM procedure between December 1993 and
May 1998 were reviewed. In addition to
demographic data, details of the operative
procedure and post operative follow up were
recorded. Complications were categorised as (1)
general, (2) flap associated or (3) abdominal.
Flap-relatedcomplicationswereclassifiedastotal
orpartialflaploss. Partialflaplosswasdefinedas
any amount of skin loss, with or without
subcutaneous tissue loss (fat necrosis). Fat
necrosis was identifiedearlyinthepostoperative
period clinically. Late fat necrosis (occurring
after 30 days) was confirmed by clinical and






by the Consultant Surgeon and Specialist Breast
Care Nurse. The major criterion in determining
suitabilitywasrequirementformastectomy. Other
criteriausedtodeterminesuitabilityincludedage
(< 60 years), body habitue (Body Mass Index
< 30), smoking status (non- smoking desirable)
and patient motivation. Previous abdominal
surgery did not exclude reconstruction. Patients
with stage IV disease were deemed unsuitable.
Surgical Technique
On the day prior to surgery markings are made to
identify the area of skin to be excised at
mastectomy and to assess the dimensions of the
flap. In immediate reconstruction, initially a
mastectomy is performed, in combination with
axillary nodeclearance asindicated. The surgical
team then rescrubs and the patient is redraped
prior to mobilisation of the abdominal flap.
This next phase of the operation involves
mobilisation of the rectus abdominis muscle
together with a lower abdominal subumbilical
transverse island of overlying fat and skin.
Following dissection of the skin island down to
the fascia of the anterior abdominal wall, the
lateralpartsoftheflaparedissectedfreeextending
medially to the borders of the rectus abdominis
muscles. Theentirewidthoftherectusabdominis
muscle which is to carry the flap (usually the
contralateral muscle) is dissected from its fascial
sheath. Theinferiorepigastric vessels aredivided
at their origin and protected to allow for
supercharging-of the pedicle if required. The
abdominal skin with the subcutaneous fat above
the flap is dissected from the abdominal wall
fascia andmobilised at least to the inferior costal
margin. An appropriately sized, oblique,
subcutaneous tunnel is created between the
mobilised abdominal skin and the mastectomy
wound.
If necessary the lateral ends of the skin and fat
islands are excised and discarded as dictated by
the segmental vascular division of the flap. The
flap pedicle, with the rectus abdominis muscle
still attached to its origin, is then delivered into
the mastectomy wound defect via the fascial
tunnel, to lie in the transverse plane. The in-situ
flap is now shaped, sized and contoured on the
chest wall, the aim being to match the other
breast, build the axillary fold, infraclavicular
groove, andtheinferiorbulkofthebreast. This is
achieved by trimming and sculpting of fat in
combination with de-epithelisation.
Therectusfasciaisapproximatedwithinterrupted
non-absorbable sutures and if required a
polypropylene mesh is used to realign the
abdominalwallandreducetension. Theumbilicus
isreimplanted, thewounds aredrainedandclosed
in two layers. Following surgery patients are
nursed semi-recumbent with their knees flexed




month, then at intervals of three months for the
first year, four months for two years and six
monthly for five years. The TRAM flap was
assessed for flap complications, cosmesis and
evidenceoflocalrecurrence. Mammography was
performed at yearly intervals.
RESULTS
In the study period 45 patients have undergone
TRAM procedure in this unit. In 37 patients
immediate reconstruction was undertaken
concurrently with mastectomy and axillary
clearance. The average age at operation was 44
years (range 26 to 57). Length of stay ranged
from 6 to 26 days (mean 9). The duration of
operation (varying from 3 hours 45 minutes to 7
hours depending on the procedures performed),
averaged 5 hours 30 minutes. Eleven patients
underwent simultaneous contralateral reduction
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mammoplasty; average operating time in this
group was six hours.
Forty-fourpatients remain underregularreview.
One patient has died as a result of disseminated
carcinoma. Systemic disease, relapse or loco-
regionalrecurrencehasnotbeenidentifiedinany
ofthe remaining 44 patients. Tumour pathology
is as shown (Table I).
TABLE I
Histological diagnoses in patients who
underwent TRAMprocedure
Invasive ductal carcinoma 34
Invasive lobular carcinoma 6
Ductal carcinoma in situ (DCIS) 2
Invasive mixed ductal/lobular 1
Mucinous carcinoma 1
Tubular carcinoma & DCIS 1
Ninepatientsdevelopedvaryingdegreesofpartial
flap loss. In three of these patients the loss was
confined to skinonly. The extentvaried from 5%
to 30% ofthe total TRAM area, 14% on average.
The skin necrosis was noted to be exclusively on
the medial aspect in six cases. One patient had
necrosis also on the lateral aspect. Six of these
nine patients were smokers and two had had
previous radiotherapy. Following skin healing
four of these developed focal modularity due to
underlying fatnecrosis. Fourpatients early inthe
series, and one more recently, required a second
woundtoiletprocedure(allperformedunderlocal
anaesthetic) for excision of skin and tissue
necrosis; one patient required two procedures.
Onerequiredrefashioningoftheflapfivemonths
after the initial procedure.
Fat necrosis (late) occurred in the TRAM flap in
onlytwocases independentofskinnecrosis. This
was minor in both cases and required no further
treatment once the diagnosis was confirmed. In
onecasefatnecrosisdevelopedfollowingawound
infection. Wehave notexperienced anytotalflap
loss to date.
There were no cardiopulmonary complications
in the series. Two patients developed confirmed
uncomplicated urinary tract infections early in
the post-operative period. There was one wound
infection which involved the abdominal wound.
There have been no abdominal herniae reported
by the patients or detected at review on clinical
examination. One patient suffered a minor
granuloma ofthe umbilicus which resolved with
application of silver nitrate. One patient has
required a minor revision (excision of dog ears)
ofthe abdominal scar. Two patients complained
ofabdominal tightness early in thepostoperative
period but this settled spontaneously.
There were no reported complications with the
reduced breast in the eleven patients who
underwent contralateral mammoplasty. No
augmentationswererequiredonthereconstructed
side, and none of the contralateral reductions or





Total flap necrosis 0
Partial flap necrosis: skin necrosis only 3
skin and fat necrosis 6
Wound infection 1
Late fat necrosis 2
Total 12/45 (27%)
Additional non-surgical treatment was
administered in 39 patients post-operatively.
Tamoxifen only was given to 16 patients,
tamoxifen combined with chemotherapy in 14
cases and chemotherapy only in five patients.
Two patients were given electron therapy to the
skin flaps above the TRAM followed by
chemotherapy. Two patients had a combination
ofelectrontherapy,chemotherapyandtamoxifen.
Reconstruction has not led to a delay in
commencement of treatment of any patient.
At follow-up (median 29 months (range 1 - 51
months)) 42 patients have had a satisfactory
cosmeticresultwithgoodsymmetry. Twopatients
have TRAM flaps which are approximately 30%
smallerthanthecontralateralbreast. Inonepatient
this was due to flap loss. One patient gained 15
kg, the gain to the TRAM flap being
disproportionate to the other breast. This patient
required reduction of the TRAM flap.
Theseresults are similarto otherpublished series
(Table III).
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TABLE III
Comparision ofpresent study withpublished series
Rosen et al15 Elliott et a113 Wilkins et a18 Andrews et al
Total patients 41 128 53 45
Type of TRAM flap
Immediate 41 128 73 38
Delayed 0 0 0 7
Pedicled 41 86 46 38
Free 0 40 27 0
Average age (years) 46 47 46 44
Days in hospital N/A 6.5 6.6 9
Operative time (hours) 4 4.8 7.6 5.5
Total flap loss (%) 0 2 0 0
Total flap complication rate(%) 24 28 29 27
DISCUSSION
As the benefits of breast reconstruction at the
time of or at a later date following mastectomy
have become more widely known by the general
public,thedemandforreconstructionfromwomen
undergoing mastectomy has increased."6 Recent
public debate concerning problems with the use
of silicone implants17' 18, 19 has led to greater
emphasis on reconstructive procedures which
use autologous tissue.12 20Ifpatients are suitable,
the TRAM flap offers the best reconstructive
results in terms of breast shape, size and
consistency.14, 17 In addition, ifit is performed at
the time ofmastectomy, it has the advantages of
a single procedure, decreased hospitalisation,
and comparable cosmetic results to delayed
reconstruction.2'
In our series the flap-related complication rate of
27%comparesfavourablytothatofotherauthors.
The nine cases of partial flap loss have had a
satisfactory outcome in all but one patient. This
patient required further surgery on the TRAM
flapandasaresulttheoverallcosmeticappearance
was suboptimal. Seven of these patients were
early in the series and such early problems have
been described by othergroups.820 Furthermore,
six of these patients were smokers and two had
hadpreviousradiotherapy. Wewouldnowregard
smoking as a relative contraindication and of
more significance than age or BMI as indirect
prognostic variables.
Our total complication rate of 36% is equivalent
to that ofother series ofTRAM reconstruction.'6
Itisalsowellbelowthecomplicationratereported
for mastectomy alone.3
Ourhospitalisation time is slightly longerthanin
othergroups. Anumberoffactors are involvedin
this. One patient stayed 26 days. Of the nine
whose stay was 12 days or longer, seven were
those who developed areas of skin necrosis and
requiredin-hospital treatmentforthis. Wewould
now manage thesepatients on an outpatientbasis
thus reducing length of stay.
Ouraverage operating time is 5 hours 30minutes
which is longer than that of other published
series.13, 15,22However, inthese seriesthesurgical
oncologist, performing the mastectomy, and the
reconstructive surgeon, commencing the flap
procedure, workintandematthebeginning ofthe
operation thereby reducing the operating time.
Both our procedures are performed by a single
surgical team.
There is no evidence that the risks to patients
undergoing the combined procedure of TRAM
flap and contralateral mammoplasty are higher
than those of the two procedures performed
separately,23 this is confirmed by our figures.
Our low rate ofabdominal wound complications
is equivalent to that experienced elsewhere. The
use ofmeshrepair, as is ourpractice, is known to
reduce the rate of abdominal hernia formation.24
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Tightening of the abdominal girth post-
operatively is a secondary benefit with which
most patients are content.
Local treatment and adjuvant therapy are not
compromised by immediate reconstruction. No
patients had their adjunctive therapy delayed or
alteredasaconsequenceofundergoingtheTRAM
procedure. Electron therapy (to non-flap skin)
has not affected the flap outcome. With a mean
follow-up of 29 months there have been no
incidences ofloco-regional recurrence. This low
rate is in keeping with other series.25 We do not
feel that reconstruction has compromised our
ability to detect loco-regional recurrence.
The findings of our study demonstrate that
immediate breast reconstruction does not
compromise patient treatment or outcome.
Although the numbers are small there does not
appear to be any difference in outcome between
immediate and delayed reconstruction. The
technique is well tolerated by the patient.
Inconclusion, ourinitial experience with TRAM
flapreconstruction has demonstrated that we can
produce an aesthetic, effective and safe means of
breast reconstruction with a complication rate
equivalent to that of the other major published
series, without compromising the treatment of
breast cancer. We therefore feel that immediate
reconstruction should be considered an integral
part of the surgical treatment of breast cancer.
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